The Clinton Health Access Initiative, Inc. (CHAI) is a global health organization committed to saving lives and reducing the burden of disease in low-and middle-income countries (LMICs), while strengthening the capabilities of governments and the private sector in those countries to create and sustain high-quality health systems that can succeed without our assistance. For more information, please visit: https://www.clintonhealthaccess.org
CHAI Vaccines program
Immunization is one of the most successful public health interventions in history. National immunization programs reach more than 100 million infants every year and have averted globally, two to three million deaths every year since the launch of the Expanded Program for Immunization (EPI) in 1974, whilst the pneumococcal conjugate vaccine (PCV) and rotavirus vaccines could save ~1 million lives per year. Furthermore, great advances in discovering and financing new vaccines provide a great opportunity for countries to further reduce the burden of disease due to virus such as the human papillomavirus (HPV). Despite these successes, 1.5 million children still die each year of vaccine-preventable diseases, many of them in low-income countries, as immunization programs there face unprecedented challenges.
Since 2010, the Clinton Health Access Initiative has worked to save lives and reduce the burden of vaccine-preventable-diseases by improving access to immunization services in resource-limited settings, by strengthening national immunization programs, and by leveraging its experience working in low-income countries to improve the global immunization ecosystem.
Overview of the CHAI Indonesia and New Vaccine Introduction work
CHAI started supporting Indonesia’s Ministry of Health in 2010 to scale up adult anti-retroviral therapy, through improving supply chain management; as well as technical assistance for improving the quality of ART and laboratory systems to support HIV care and treatment. In recent years, CHAI has expanded its support to the Ministry of Health to other areas including hepatitis and helping to facilitate BMS to and donate pan genotyping DAA, daclatasvir, more effective treatment for HCV patient, improving access to family planning, point of care diagnostics, mhealth, maternal and child health, scooping assistive technology in Indonesia so no one left behind, and technical support for the Ministry of Health’s drive to sustainably fund healthcare. In mid-2016, CHAI launched its vaccines program to support the EPI and Ministry of Health in Indonesia introduce the Pneumococcal Conjugate Vaccine (PCV) and strengthen broader immunization systems, including cold chain, supply chain, and immunization financing, among other things. From 2017-2019 CHAI supported the government execute a PCV demonstration project in select districts as well as support national-level decision-making on PCV introduction.
In early 2020, the government of Indonesia announced their decision to introduce PCV nationwide and to procure vaccines through the Advance Market Commitment (AMC). CHAI will continue to support the government with PCV introduction, by focusing on the following objectives:
In addition to PCV, the government of Indonesia is planning for several additional new vaccine introductions over the coming years and CHAI may in the future be brought in to provide support beyond PCV.
Overview of the Vaccines Program Officer role
Reporting to the Program Manager, the Program Officer will support efforts to deliver the ambitious objectives of PCV work and any future new vaccine introduction work that may be added to CHAI’s scope of work. S/he will provide both strategic and technical support to the government of Indonesia in planning and implementing PCV introduction, including but not limited to: data analysis, synthesis of research/information in memos and presentations, design of data collection tools, training material, and compilation of lessons learned and best practices. The program officer will work closely with all members of the Indonesia Vaccines program as well as CHAI’s Global Vaccines Delivery team.